← Back to Clinical Trials
Recruiting NCT06538792
NCT06538792 Proprioception, Muscle Strength and Kinesiophobia After Anterior Cruciate Ligament Reconstruction
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06538792 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bezmialem Vakif University |
| Condition | Anterior Cruciate Ligament Reconstruction |
| Study Type | OBSERVATIONAL |
| Enrollment | 52 participants |
| Start Date | 2024-11-09 |
| Primary Completion | 2026-05 |
Trial Parameters
Condition Anterior Cruciate Ligament Reconstruction
Sponsor Bezmialem Vakif University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 52
Sex ALL
Min Age 18 Years
Max Age 35 Years
Start Date 2024-11-09
Completion 2026-05
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Fear of re-injury after anterior cruciate ligament reconstruction surgery (ACLR) affects individuals' return to sports and physical activity negatively. The aim of this study is to evaluate the effects of proprioception and muscle strength on kinesiophobia in patients who have undergone anterior cruciate ligament reconstruction surgery.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18-35 * History of ACL reconstruction surgery at least 6 months ago Exclusion Criteria: * History of previous lower extremity surgery * History of lower extremity injury within the last 6 months * Having a vestibular or neurologic pathology that would affect balance
Related Trials
NCT06206200
The Effects of Cognitive Dual-Tasking in Later Stages of Rehabilitation After ACL Reconstruction
View Trial →
NCT06538792
Proprioception, Muscle Strength and Kinesiophobia After Anterior Cruciate Ligament Reconstruction
View Trial →
NCT06858293
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feas
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology